
+ND Capital
Description
+ND Capital, formerly known as NanoDimension, is a prominent venture capital firm based in San Mateo, California, with a distinct focus on disruptive technologies. The firm specializes in investments at the convergence of the life and physical sciences, targeting innovations that promise significant societal and economic impact. Their investment thesis centers on deep technology, encompassing a broad spectrum of sectors including biotechnology, medtech, diagnostics, digital health within life sciences, and advanced materials, quantum computing, artificial intelligence, robotics, and climate tech within physical sciences. This dual-pronged approach allows +ND Capital to identify and nurture groundbreaking companies that often bridge traditional scientific disciplines.
The firm typically acts as the first institutional investor, engaging with companies from the seed stage through Series B rounds. This early-stage commitment underscores their belief in long-term partnerships and their willingness to provide foundational capital to nascent ventures. +ND Capital is known for its hands-on approach, leveraging the extensive scientific and entrepreneurial expertise of its team to support portfolio companies beyond just capital injection. They aim to help founders navigate the complex journey from scientific discovery to market-ready products, emphasizing robust intellectual property and scalable business models.
Financially, +ND Capital has demonstrated significant fundraising capabilities, reflecting investor confidence in their strategy and execution. For instance, the firm successfully closed its Fund IV in March 2022, securing $350 million in commitments. Prior to this, their Fund III closed at $250 million in 2018, illustrating a consistent growth in their capital base. When it comes to initial investments, +ND Capital typically deploys first checks ranging from $1 million to $10 million. This initial investment range is complemented by substantial reserves earmarked for follow-on investments, ensuring that promising portfolio companies receive continued support as they achieve milestones and scale their operations. Their strategy is to build a concentrated portfolio of high-potential ventures, providing them with the necessary resources to achieve commercial success and drive technological advancement.
Investor Profile
+ND Capital has backed more than 56 startups, with 6 new investments in the last 12 months alone. The firm has led 14 rounds, about 25% of its total and boasts 12 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series A rounds (top funding stages).
- Majority of deals are located in United States, Switzerland, United Kingdom.
- Strong thematic focus on Biotechnology, Health Care, Medical.
- Led 1 rounds in the past year.
- Typical check size: $1M – $10M.
Stage Focus
- Series B (25%)
- Series C (23%)
- Series A (18%)
- Series D (13%)
- Series Unknown (11%)
- Seed (5%)
- Series E (4%)
- Private Equity (2%)
Country Focus
- United States (82%)
- Switzerland (9%)
- United Kingdom (4%)
- Denmark (4%)
- France (2%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Life Science
- Software
- Therapeutics
- Pharmaceutical
- Semiconductor
- Artificial Intelligence (Ai)
- Electronics
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.